Omega-3 Fatty Acid Pet Food Formulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Companion pets, such as dogs and cats, often lack sufficient omega-3 fatty acids in their diets, which are essential for maintaining healthy behavior and cognitive function, particularly in young, adult, and aged animals, and existing pet food compositions do not adequately provide these essential fatty acids.
Innovation Solution
Systemic administration of a behavior-influencing quantity of omega-3 fatty acids, preferably EPA and DHA, in a diet or supplement form, ensuring a minimum of 0.5 wt.% to 10 wt.% on a dry matter basis, to promote positive behavioral changes and cognitive health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If typical pet food compositions are used, then the food is readily available and easy to administer, but the omega-3 fatty acid content is insufficient to influence behavior positively
Solution Approach 1:
The patent combines omega-3 fatty acid supplements with pet food formulations, merging two separate components (food and supplement) into a unified behavioral health solution. This allows the pet food to simultaneously provide nutrition and behavior-influencing quantities of omega-3 fatty acids without requiring separate administration routines.
Solution Approach 2:
The patent changes the concentration parameter of omega-3 fatty acids in pet food from typical low levels to behavior-influencing quantities (specific ranges disclosed). This parameter change transforms the food from merely nutritional to therapeutically effective for behavior modification while maintaining the same basic food formulation approach.
2Reliability
If omega-3 fatty acids are administered systemically in proper quantities, then behavior is positively influenced, but the administration requires careful dosage control
Solution Approach 1:
The patent establishes a feedback loop where behavioral observations in pets guide adjustments to omega-3 fatty acid dosing. The method monitors behavioral changes and uses this information to determine whether continued supplementation is effective, allowing for evidence-based dosage management that balances reliability with practical simplicity.
Solution Approach 2:
The patent provides preliminary guidance on dosing ranges and administration protocols before behavioral outcomes are observed. By establishing predetermined dosage ranges and administration schedules in advance, the method reduces the complexity of real-time dosage decision-making while maintaining reliable behavioral improvement through pre-planned nutritional intervention.
Data Source
AI summary
A method for influencing behavior in young, adult or aged pet animals which comprises systemically administering a behavior influencing quantity of an omega-3 fatty acid or mixture of omega-3 fatty acids.